T.G. Winstanley
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 10
-
- Bacterial Identification and Susceptibility Testing 10
- Co-authors
- J. M. HardieRobert A. WhileyD. BeightonGunnar KahlmeterRoland LeclercqJohan W. MoutonChristian G. GiskeAlasdair MacGowan
- Journals
- Journal of Antimicrobial Chemotherapy (10 papers)Journal of Clinical Pathology (4 papers)Journal of Medical Microbiology (2 papers)Clinical Microbiology and Infection (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesNorway
In The Last Decade
T.G. Winstanley
25 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Medicine 357
- Applied Microbiology and Biotechnology 102
- Clinical Biochemistry 248
- Endocrinology 144
- Microbiology 89
Countries citing papers authored by T.G. Winstanley
This map shows the geographic impact of T.G. Winstanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.G. Winstanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.G. Winstanley more than expected).
Fields of papers citing papers by T.G. Winstanley
This network shows the impact of papers produced by T.G. Winstanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.G. Winstanley. The network helps show where T.G. Winstanley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside T.G. Winstanley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | EUCAST expert rules in antimicrobial susceptibility testing Hit paper breakdown → | 2011 | 502 |
| 2 | 2010 | 48 | |
| 3 | 2009 | 16 | |
| 4 | 2005 | 3 | |
| 5 | Case Study: Cancrum oris (noma) in a malnourished HIV-positive child from rural Kwazulu-Natal | 2004 | 1 |
| 6 | Cancrum oris (noma) in a malnourished HIV-positive child from rural KwaZulu-Natal | 2004 | 5 |
| 7 | 2001 | 51 | |
| 8 | 1997 | 3 | |
| 9 | 1997 | 3 | |
| 10 | 1997 | 69 | |
| 11 | 1996 | 4 | |
| 12 | 1996 | 5 | |
| 13 | 1995 | 2 | |
| 14 | 1994 | 16 | |
| 15 | 1993 | 22 | |
| 16 | 1993 | 3 | |
| 17 | 1992 | 15 | |
| 18 | 1991 | 20 | |
| 19 | 1990 | 13 | |
| 20 | 1989 | 19 |
About T.G. Winstanley
T.G. Winstanley is a scholar working on Molecular Medicine, Clinical Biochemistry, Endocrinology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Bacterial Identification and Susceptibility Testing (10 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Streptococcal Infections and Treatments (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Urinary Tract Infections Management (3 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Molecular Medicine (357 citations), Applied Microbiology and Biotechnology (102 citations), Clinical Biochemistry (248 citations), Endocrinology (144 citations) and Microbiology (89 citations). T.G. Winstanley has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include J. M. Hardie, Robert A. Whiley, D. Beighton, Gunnar Kahlmeter, Roland Leclercq, Johan W. Mouton, Christian G. Giske, Alasdair MacGowan, Patrice Nordmann and C J Soussy. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Clinical Pathology, Journal of Medical Microbiology, Clinical Microbiology and Infection and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.